Market Value114,419,671
Total Holdings85
File Date2026-02-06
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RVMD / Revolution Medicines, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
RPRX / Royalty Pharma plc
ASND / Ascendis Pharma A/S
WVE / Wave Life Sciences Ltd.
CRNX / Crinetics Pharmaceuticals, Inc.
CRSP / CRISPR Therapeutics AG
CLDX / Celldex Therapeutics, Inc.
KOD / Kodiak Sciences Inc.
EXEL / Exelixis, Inc.
MAZE / Maze Therapeutics, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
ROIV / Roivant Sciences Ltd.
MNMD / Mind Medicine (MindMed) Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
XENE / Xenon Pharmaceuticals Inc.
PTGX / Protagonist Therapeutics, Inc.
OCUL / Ocular Therapeutix, Inc.
UPB / Upstream Bio, Inc.
INSM / Insmed Incorporated
ACAD / ACADIA Pharmaceuticals Inc.
CYTK / Cytokinetics, Incorporated
ARWR / Arrowhead Pharmaceuticals, Inc.
PRAX / Praxis Precision Medicines, Inc.
APLS / Apellis Pharmaceuticals, Inc.
VKTX / Viking Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
DNLI / Denali Therapeutics Inc.
AUPH / Aurinia Pharmaceuticals Inc.
TVTX / Travere Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
INCY / Incyte Corporation
DNTH / Dianthus Therapeutics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
ALKS / Alkermes plc
HALO / Halozyme Therapeutics, Inc.
KNSA / Kiniksa Pharmaceuticals International, plc
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
CELC / Celcuity Inc.
EYPT / EyePoint, Inc.
STOK / Stoke Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
CGON / CG Oncology, Inc.
BBIO / BridgeBio Pharma, Inc.
LQDA / Liquidia Corporation
PTCT / PTC Therapeutics, Inc.
MLYS / Mineralys Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc.
UTHR / United Therapeutics Corporation
BMRN / BioMarin Pharmaceutical Inc.
JAZZ / Jazz Pharmaceuticals plc
BEAM / Beam Therapeutics Inc.
PHVS / Pharvaris N.V.
MDGL / Madrigal Pharmaceuticals, Inc.
BLTE / Belite Bio, Inc - Depositary Receipt (Common Stock)
ZYME / Zymeworks Inc.
SGOV / iShares Trust - iShares 0-3 Month Treasury Bond ETF
INBX / Inhibrx Biosciences, Inc.
COGT / Cogent Biosciences, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
TGTX / TG Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
SUPN / Supernus Pharmaceuticals, Inc.
VERA / Vera Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
IMNM / Immunome, Inc.
PVLA / Palvella Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
NUVL / Nuvalent, Inc.
OLMA / Olema Pharmaceuticals, Inc.
NRIX / Nurix Therapeutics, Inc.
ALMS / Alumis Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
RAPP / Rapport Therapeutics, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
ACLX / Arcellx, Inc.
SYRE / Spyre Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.